Engineered Escherichia coli as a Controlled-Release Biocarrier for Electrochemical Immunoassay

Nano Lett. 2023 Apr 12;23(7):2854-2861. doi: 10.1021/acs.nanolett.3c00184. Epub 2023 Mar 17.

Abstract

Micro/nanocarriers hold great potential in bioanalysis for molecular recognition and signal amplification but are frequently hampered by harsh synthesis conditions and time-consuming labeling processes. Herein, we demonstrate that Escherichia coli (Ec) can be engineered as an efficient biocarrier for electrochemical immunoassay, which can load ultrahigh amounts of redox indicators and simultaneously be decorated with detection antibodies via a facile polydopamine (PDA)-mediated coating approach. Compared with conventional carrier materials, the entire preparation of the Ec biocarrier is simple, highly sustainable, and reproducible. Moreover, immune recognition and electrochemical transduction are performed independently, which eliminates the accumulation of biological interference on the electrode and simplifies electrode fabrication. Using human epidermal growth factor receptor 2 (HER2) as the model target, the proposed immunosensor exhibits excellent analytical performance with a low detection limit of 35 pg/mL. The successful design and deployment of Ec biocarrier may provide new guidance for developing biohybrids in biosensing applications.

Keywords: Escherichia coli; HER2 detection; PDA chemistry; biocarrier; electrochemical immunosensor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biosensing Techniques*
  • Delayed-Action Preparations
  • Escherichia coli
  • Humans
  • Immunoassay
  • Limit of Detection

Substances

  • Delayed-Action Preparations